Mirum Pharmaceuticals, Inc.
MIRM
51 insider filings · Latest: Aug 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 4 2:45 AM | Jolanda HoweSVP, GLOBAL CONTROLLER | Sale | 968 | $103.30 | $100.0K | 4,503(D) | View → |
| Feb 2, 2026 | Feb 3 1:29 AM | Jolanda Howe | Proposed Sale | 968 | $103.80 | $100.5K | — | View → |
| Feb 2, 2026 | Feb 3 1:25 AM | Peter Radovich | Proposed Sale | 2,631 | $103.80 | $273.1K | — | View → |
| Feb 2, 2026 | Feb 3 1:21 AM | Christopher Peetz | Proposed Sale | 9,108 | $103.80 | $945.4K | — | View → |
| Jan 26, 2026 | Jan 28 11:47 PM | Jolanda Howe | Proposed Sale | 842 | $96.92 | $81.6K | — | View → |
| Jan 26, 2026 | Jan 28 11:44 PM | ERIC BJERKHOLT | Proposed Sale | 1,053 | $96.92 | $102.1K | — | View → |
| Jan 26, 2026 | Jan 28 11:43 PM | Peter Radovich | Proposed Sale | 3,143 | $96.92 | $304.6K | — | View → |
| Jan 26, 2026 | Jan 28 11:40 PM | Christopher Peetz | Proposed Sale | 6,831 | $96.92 | $662.1K | — | View → |
| Jan 26, 2026 | Jan 27 9:30 PM | Eric BjerkholtCHIEF FINANCIAL OFFICER | Sale | 1,053 | $96.19 | $101.3K | 43,741(D) | View → |
| Jan 26, 2026 | Jan 27 9:30 PM | Peter RadovichPRESIDENT AND COO | Sale | 3,143 | $96.19 | $302.3K | 23,286(D) | View → |
| Jan 26, 2026 | Jan 27 9:30 PM | Jolanda HoweSVP, GLOBAL CONTROLLER | Sale | 842 | $96.19 | $81.0K | 3,700(D) | View → |
| Jan 26, 2026 | Jan 27 9:30 PM | Christopher PeetzDirector, CHIEF EXECUTIVE OFFICER | Sale | 6,831 | $96.19 | $657.1K | 169,402(D) | View → |
| Jan 23, 2026 | Jan 27 9:14 PM | Patrick J HeronDirector | Purchase | 131,425 | $68.48 | $9.0M | 459,010(I) | View → |
| Jan 22, 2026 | Jan 23 10:30 PM | Jolanda HoweSVP, GLOBAL CONTROLLER | Sale | 926 | $93.33 | $86.4K | 3,042(D) | View → |
| Jan 22, 2026 | Jan 23 10:30 PM | Joanne QuanCHIEF MEDICAL OFFICER | Sale | 1,822 | $93.33 | $170.0K | 12,817(D) | View → |
| Jan 22, 2026 | Jan 23 10:30 PM | Eric BjerkholtCHIEF FINANCIAL OFFICER | Sale | 1,421 | $93.33 | $132.6K | 42,127(D) | View → |
| Jan 22, 2026 | Jan 23 10:30 PM | Peter RadovichPRESIDENT AND COO | Sale | 2,382 | $93.33 | $222.3K | 20,679(D) | View → |
| Jan 22, 2026 | Jan 23 10:30 PM | Christopher PeetzDirector, CHIEF EXECUTIVE OFFICER | Sale | 7,098 | $93.33 | $662.4K | 163,733(D) | View → |
| Jan 20, 2026 | Jan 21 9:05 PM | Joanne QuanCHIEF MEDICAL OFFICER | Sale | 6,911 | $90.27 | $623.9K | 11,305(D) | View → |
| Jan 15, 2026 | Jan 15 9:02 PM | SAIRA RAMASASTRY | Proposed Sale | 2,000 | $90.99 | $182.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | Jan 23 10:30 PM | Peter RadovichPRESIDENT AND COO | Option Exercise | 4,167 | — | 8,333(D) | View → |
| Jan 21, 2026 | Jan 23 10:30 PM | Christopher PeetzDirector, CHIEF EXECUTIVE OFFICER | Option Exercise | 12,797 | — | 25,593(D) | View → |
| Jan 16, 2026 | Jan 21 9:05 PM | Joanne QuanCHIEF MEDICAL OFFICER | Option Exercise | 12,500 | — | 12,500(D) | View → |
← Previous
Page 3 of 3